Company intelligence / Profile preview

Hong Kong Pharma Digital Technology

Hong Kong, Hong Kong

Ownership: Private
Employees: ~19
Development stage: Other

Overview

The company provides cross-border e-commerce logistics, supply chain, and distribution for OTC pharmaceuticals; it is ranked as the leading service provider in Mainland China's OTC cross-border e-commerce sector by revenue in 2022 according to Frost & Sullivan. It catalogues over 6,000 SKUs (mostly OTC), including >4,000 authorized for cross-border distribution by the Hong Kong Department of Health. No clinical programs; business is infrastructure/logistics, not drug development.

Modalities: Small moleculeTraditional Chinese medicineHealth supplements
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Hangzhou Cainiao Supply Chain Management Co., Ltd.TmallJD.comPinduoduoMeituanXiaohongshuYouzan

Beyond the preview

Go deeper on Hong Kong Pharma Digital Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hong Kong Pharma Digital Technology.

Explore the full profile